Xilio Therapeutics XLO
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 8.96 | 35 | 10 | 7.18 | 155 | |
| 2025Q3 | 11.80 | -8 | -16 | -12.18 | 134 | |
| 2025Q2 | 9.52 | 7 | -178.33 | -16 | -13.34 | 134 |
| 2025Q1 | 10.14 | 11 | -93.75 | -13 | -15.18 | 104 |
| 2024Q4 | 13.37 | 18 | -67.89 | -13 | -17.97 | 71 |
| 2024Q3 | 11.03 | 21 | -51.55 | -14 | -17.04 | 75 |
| 2024Q2 | 13.27 | 33 | -47.06 | -14 | -16.15 | 90 |
| 2024Q1 | 15.12 | 26 | -54.97 | -17 | -23.97 | 83 |
| 2023Q4 | 7.70 | 37 | -39.53 | -18 | -25.45 | 61 |
| 2023Q3 | 29.54 | 52 | -27.94 | -17 | -19.68 | 78 |
| 2023Q2 | 36.68 | 67 | -25.44 | -19 | -18.99 | 92 |
| 2023Q1 | 44.38 | 85 | -23.78 | -23 | -18.07 | 112 |
| 2022Q4 | 37.66 | 106 | -19.37 | -22 | -15.15 | 139 |
| 2022Q3 | 40.74 | 126 | -14.63 | -20 | -11.80 | 157 |
| 2022Q2 | 40.88 | 144 | -15.86 | -25 | -13.15 | 178 |
| 2022Q1 | 98.98 | 166 | -12.15 | -21 | -10.31 | 196 |
| 2021Q4 | 224.00 | 185 | -20 | -11.63 | 218 | |
| 2021Q3 | -136 | -16 | -12.46 | 121 | ||
| 2021Q2 | -121 | -23 | 140 | |||
| 2021Q1 | -17 |